Revenio Group Corporation : DECISIONS BY THE ANNUAL GENERAL MEETING ON 20.3.2014

Revenio Group Corporation         Stock Exchange Release 20.03.2014 at 5 p.m.

DECISIONS BY THE ANNUAL GENERAL MEETING OF REVENIO GROUP CORPORATION
ON 20.3.2014

1. Financial statements, Board and auditors

The AGM confirmed the company's financial statements for the financial year 1
January - 31 December 2013, and discharged the members of the Board of Directors
and the Managing Director from liability.

The AGM decided that five members be elected to the Board of Directors and re-
elected Rolf Fryckman, Ari Kohonen and Pekka Tammela as board members, while
also appointing Kyösti Kakkonen and Pekka Rönkä as members. In its meeting held
after the AGM, the Board of Directors re-elected Pekka Tammela as chairman.

The AGM decided that the Chairman of the Board be entitled to an annual
emolument of EUR 36,000 and the other Board members to an annual emolument of
EUR 18,000.

A total of 40 per cent of Board members' emoluments will be settled in the form
of company shares, while 60 per cent will comprise a monetary payment.

The AGM re-elected PricewaterhouseCoopers Oy, Authorized Public Accountants, as
the company's auditors with Juha Tuomala, Authorized Public Accountant, acting
as the principal auditor. The AGM decided to compensate the auditors, upon the
presentation of a reasonable invoice.

2. Annual profit distribution, dividend distribution and capital repayment

The AGM decided to accept the Board's proposal on profit distribution, according
to which the profit for the financial period, EUR -304,972.66, will be added to
retained earnings, and a dividend of EUR 0.3 per share will be paid. Dividends
will be paid to shareholders who have been registered in the company's
shareholder register, maintained by Euroclear Finland Ltd, by the dividend
record date on March 25, 2014. The dividend payment date is April 3, 2014.

3. Authorizing the Board of Directors to decide to repurchase the Company's own
shares

The AGM rescinded its earlier authorization to buy back 771,107 of the company's
own shares and authorized the Board to make the decision to buy back a maximum
of 785,047 of the company's own shares, in one or more installments, using the
company's unrestricted equity, in which case any buyback will reduce the amount
of company distributable earnings. The company may buy back shares in order to
develop its capital structure, to finance and implement any corporate
acquisitions or other transactions, and to implement share-based incentive plans
or otherwise dispose of or cancel them.

The Company may buy back shares, based on

a. A bid submitted to all shareholders on equal terms and conditions in
proportion to their current holdings in Company shares and at the same price,
decided by the Board of Directors; or

b. in public trading on marketplaces whose rules and regulations allow the
Company to trade in its own shares. In such a case, the Company will buy back
shares through a directed purchase, that is, in a proportion other than its
shareholders' holdings in Company shares, with the consideration for the shares
based on their publicly quoted market price.

This authorization will be valid until April 30, 2015.

4. Authorizing the Board of Directors to decide on a share issue and on the
granting of stock options and other special rights conferring entitlement to
shares The AGM authorized the Board of Directors to decide on the issuance,
following the approval of the reverse share split, of a maximum of 3,000,000
shares or to grant special rights (including stock options) conferring
entitlement to shares, as referred to in Section 1 of Chapter 10 of the Limited
Liability Companies Act, in one or several tranches.

This authorization was granted for the purpose of financing and implementing any
prospective corporate acquisitions or other transactions, implementing the
company's share-based incentive plans, or for other purposes determined by the
Board.

The authorization encompasses the Board's right to decide on all terms and
conditions governing said share issue and the granting of special rights,
including the subscribers or grantees of said special rights and the payable
consideration. Moreover, the authorization also includes the right to waive
shareholders' pre-emptive subscription rights, thus enabling private placement
of shares. The Board's authorization covers both the issue of new shares and the
transfer of any treasury shares possibly held by the Company.

The Board proposes that the authorization be valid until April 30, 2015. This
authorization shall supersede the authorization to decide on a share issue and
on the granting of special rights giving entitlement to shares granted in the
AGM of March 21, 2013.

Revenio Group Corporation

Board of Directors


For additional information:
Olli-Pekka Salovaara, CEO and President, +358 40 567 5520
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi

DISTRIBUTION:

NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy. The widely patented Icare product family is the current cornerstone of the
Group's success. Revenio seeks vigorous growth in health technology,
both organically and through acquisitions and mergers. The Revenio Group also
includes other business operations, which are grouped under the Technology and
Services segment. This segment's operations have a shared global market and
represent the cutting edge of technology products and services in
their industry. These businesses are extremely profitable in their industries
and generate positive cash flow.

In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.

[HUG#1769483]